Holen Sie sich die Stockscreener-App
1.79
2.72%
-0.05
Schlusskurs vom Vortag:
$1.84
Offen:
$1.82
24-Stunden-Volumen:
2,249
Relative Volume:
0.02
Marktkapitalisierung:
$75.84M
Einnahmen:
$6.21M
Nettoeinkommen (Verlust:
$-19.92M
KGV:
-1.7048
EPS:
-1.05
Netto-Cashflow:
$-16.76M
1W Leistung:
-3.76%
1M Leistung:
-1.10%
6M Leistung:
-26.34%
1J Leistung:
-35.38%
1-Tages-Spanne:
$1.79
$1.82
1-Wochen-Bereich:
$1.74
$1.95
52-Wochen-Spanne:
$1.59
$3.798
InspireMD Inc. Stock (NSPR) Company Profile
Firmenname
InspireMD Inc.
Sektor
Branche
Telefon
972 3 6917691
Adresse
4 Menorat Hamaor Street, Tel Aviv
Vergleichen Sie NSPR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NSPR
InspireMD Inc.
|
1.79 | 77.96M | 6.21M | -19.92M | -16.76M | -1.05 |
|
ABT
Abbott Laboratories
|
125.50 | 219.41B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.69 | 145.84B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.18 | 140.43B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
97.49 | 126.52B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.14 | 49.08B | 5.88B | 1.34B | 799.60M | 2.3489 |
InspireMD Inc. Stock (NSPR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2016-01-07 | Eingeleitet | Rodman & Renshaw | Buy |
| 2015-03-13 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2013-11-26 | Eingeleitet | Oppenheimer | Outperform |
InspireMD Inc. Aktie (NSPR) Neueste Nachrichten
Will InspireMD Inc. (II2) stock outperform value peersProfit Target & Expert Approved Momentum Trade Ideas - ulpravda.ru
Will InspireMD Inc. stock continue dividend increasesMarket Growth Report & Advanced Technical Signal Analysis - ulpravda.ru
Will InspireMD Inc. (II2) stock benefit from sector leadership2025 Macro Impact & Weekly Return Optimization Alerts - ulpravda.ru
How InspireMD Inc. stock compares to growth peersTrade Exit Summary & Daily Entry Point Trade Alerts - ulpravda.ru
InspireMD (NYSE:NSPR) Trading Down 6.2%Should You Sell? - MarketBeat
InspireMD (NYSE:NSPR) Trading Down 6.2% – Should You Sell? - Defense World
InspireMD (NSPR) price target decreased by 11.11% to 4.08 - MSN
Head to Head Analysis: InspireMD (NYSE:NSPR) versus Minerva Surgical (NASDAQ:UTRS) - Defense World
Is InspireMD (NASDAQ:NSPR) In A Good Position To Invest In Growth? - Sahm
Will InspireMD Inc. stock gain from lower inflationWeekly Trade Analysis & Low Risk Entry Point Guides - Улправда
Working capital per share of InspireMD Inc. – DUS:II2 - TradingView — Track All Markets
Can InspireMD Inc. stock hit record highs again2025 Breakouts & Breakdowns & Stepwise Swing Trade Plans - Улправда
Aug Update: Will InspireMD Inc. (II2) stock outperform value peersJuly 2025 Catalysts & Safe Capital Preservation Plans - Улправда
Why InspireMD Inc. stock is considered a top pickJuly 2025 Highlights & Weekly High Return Forecasts - Улправда
Will InspireMD Inc. (II2) stock profit from fiscal stimulusBreakout Watch & Verified Momentum Watchlists - Улправда
InspireMD’s new study on neuroprotection system: A potential game-changer? - MSN
Why InspireMD Inc. stock could be next big winnerTreasury Yields & Risk Managed Investment Strategies - DonanımHaber
Is InspireMD Inc a good long term investmentREITs Market Trends & Capital Efficiency Improvement - earlytimes.in
InspireMD’s Pivotal Study on CGuard Prime Stent System: A Potential Game-Changer - MSN
InspireMD’s New Study on Neuroprotection System: A Potential Game-Changer? - TipRanks
Aug Selloffs: How InspireMD Inc stock compares to growth peers2025 Institutional Moves & Daily Growth Stock Tips - moha.gov.vn
Head-To-Head Review: Biotricity (NASDAQ:BTCY) versus InspireMD (NYSE:NSPR) - Defense World
Peter A. Soukas Joins InspireMD as Chief Medical Officer - Medical Product Outsourcing
Investment Report: Will InspireMD Inc stock gain from lower inflationWeekly Stock Analysis & Reliable Price Breakout Signals - moha.gov.vn
Total debt per share of InspireMD Inc. – MUN:II2 - TradingView
InspireMD Director Paul Stuka Acquires 10,130 Shares - TradingView
Dir Stuka Buys 10,130 ($18.7K) Of InspireMD Inc [NSPR] - TradingView — Track All Markets
Can InspireMD Inc. (II2) stock survive global slowdownM&A Rumor & High Conviction Trade Alerts - Newser
Is InspireMD Inc. (II2) stock supported by strong fundamentalsWeekly Gains Summary & Weekly Sector Rotation Insights - Newser
InspireMD (NSPR) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Financial Contrast: InspireMD (NYSE:NSPR) vs. Biostage (OTCMKTS:BSTG) - Defense World
How InspireMD Inc. stock performs in rate cut cyclesTreasury Yields & Verified Swing Trading Watchlists - BỘ NỘI VỤ
InspireMD Reports Fourth Quarter and Full Year 2024 Financial Results - ADVFN
InspireMD (NYSE:NSPR) Shares Up 2%Should You Buy? - MarketBeat
InspireMD announces publication of CREST-2 data in NEJM - MSN
Lake Street Reaffirms Their Buy Rating on InspireMD (NSPR) - The Globe and Mail
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(4) - MarketScreener
InspireMD Celebrates Positive Outcomes from CREST-2 Study Supporting Carotid Stenting for Asymptomatic Patients - Quiver Quantitative
Landmark CREST-2 Study Published in the New England Journal of Medicine Highlights the Benefits of Carotid Artery Stenting - The Manila Times
Landmark CREST-2 Study Published in the New England Journal - GlobeNewswire
InspireMD announces inducement grants - Medical Buyer
InspireMD Reports Record Revenue Amid U.S. Launch - MSN
What analysts say about InspireMD Inc stockMarket Correction Analysis & Low Entry Cost Trading - earlytimes.in
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
InspireMD (Nasdaq: NSPR) grants 122,054 inducement shares to eight new hires - Stock Titan
What catalysts could drive InspireMD Inc. stock higherEarnings Recap Summary & Capital Efficiency Focused Ideas - newser.com
Is InspireMD Inc. (II2) stock suitable for passive index fundsOil Prices & Capital Protection Trade Alerts - newser.com
InspireMD to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference - The Manila Times
Why analysts remain bullish on InspireMD Inc. stockDollar Strength & Real-Time Buy Signal Alerts - newser.com
Finanzdaten der InspireMD Inc.-Aktie (NSPR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.54%
0.49%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):